Summary
Carlos Talavera-López is a clinician-turned-computational biologist with a decade of experience translating single-cell and spatial multi-omics into target discovery and translational insights across academia and industry. Currently Director of Target Discovery Sciences at GSK, he leads integrative, spatially-resolved multi-omics programs that pair generative and agentic AI to characterize disease mechanisms and nominate novel targets. His career spans leading roles at premier institutions (Wellcome Sanger, EMBL-EBI, Max Planck, Helmholtz) where he built FAIR cloud pipelines, atlases of human tissues, and graph-learning methods to study cellular collectives. He has a unique combination of front-line clinical training in Nicaragua and deep technical PhD expertise from Karolinska that informs pragmatic biomarker and trial innovations, including adaptive AI-driven clinical trials for tuberculosis. Colleagues value him for bridging rigorous computational method development with actionable translational impact across global, multi-site consortia.
10 years of coding experience
5 years of employment as a software developer
Clinical Analyst, Medicine, Clinical Analyst, Medicine at Universidad Nacional Autónoma de Nicaragua UNAN-León
Doctor of Philosophy (PhD), Computational Biology, Doctor of Philosophy (PhD), Computational Biology at Karolinska institutet
Spanish, English, German, Swedish